THC May Protect Brain Cells From HIV-Related Aging and Inflammation
In a primate model of HIV, THC treatment reversed virus-induced premature aging of brain support cells (astrocytes) and reduced inflammatory signaling, suggesting cannabinoids could help protect the brain during chronic HIV infection.
Quick Facts
What This Study Found
THC treatment protected astrocytes from SIV-induced senescence (premature cellular aging), promoted recovery from Tat protein-induced damage, enhanced neuroprotective cell morphology, and significantly reduced inflammatory cytokines TNF-α, IL-6, and IL-1β in a dose-dependent manner.
Key Numbers
THC significantly reduced TNF-α, IL-6, and IL-1β secretion in a dose-dependent manner. THC promoted glial process elongation and morphological complexity indicative of a neuroprotective phenotype.
How They Did This
Researchers used primary mixed glial cultures from rhesus macaques, assessing cell integrity via real-time impedance monitoring (xCELLigence), morphology via phase-contrast microscopy, and cytokine levels via multiplex immunoassays after THC and HIV Tat protein exposure.
Why This Research Matters
Despite effective antiretroviral therapy, chronic brain inflammation remains a major problem for people living with HIV. This study suggests THC could address this unmet need by reversing cellular aging and reducing inflammation in brain support cells.
The Bigger Picture
About half of people living with HIV experience some form of neurocognitive impairment despite effective antiretroviral therapy. If THC's neuroprotective effects translate from primate models to humans, it could offer an adjunct therapeutic strategy for HIV-associated brain injury.
What This Study Doesn't Tell Us
Preclinical study using primate cell cultures — results may not directly translate to humans. The study examined THC in isolation, not as part of whole-plant cannabis. Dose-response relationships in cell culture may differ from clinical dosing.
Questions This Raises
- ?Would THC show similar neuroprotective effects in human clinical trials of people living with HIV?
- ?Could cannabinoid therapy complement antiretroviral treatment for neurocognitive symptoms?
- ?What is the optimal dosing window?
Trust & Context
- Key Stat:
- Evidence Grade:
- Preclinical study using primate-derived cell cultures with multiple validated assessment methods, but no human clinical data.
- Study Age:
- Published 2025.
- Original Title:
- THC reverses SIV-induced senescence in astrocytes: possible compensatory mechanism against HIV associated brain injury?
- Published In:
- Frontiers in cellular neuroscience, 19, 1642917 (2025)
- Authors:
- Van Zandt, Alison R, Horn, Miranda D, Peterson, Tiffany A, Dickinson, Sarah Y, Frost, Elise M, MacLean, Andrew G
- Database ID:
- RTHC-07851
Evidence Hierarchy
Frequently Asked Questions
Should people with HIV use THC for brain protection?
This is early preclinical research using cell cultures. While promising, it has not been tested in human clinical trials. People living with HIV should discuss any cannabis use with their healthcare provider.
Why are astrocytes important in HIV brain disease?
Astrocytes are the most abundant brain support cells. When HIV causes them to age prematurely (senesce), they release inflammatory signals that damage surrounding neurons, contributing to cognitive decline.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
- why-does-weed-make-music-sound-better
- why-does-weed-give-cotton-mouth-salivary
Cite This Study
https://rethinkthc.com/research/RTHC-07851APA
Van Zandt, Alison R; Horn, Miranda D; Peterson, Tiffany A; Dickinson, Sarah Y; Frost, Elise M; MacLean, Andrew G. (2025). THC reverses SIV-induced senescence in astrocytes: possible compensatory mechanism against HIV associated brain injury?. Frontiers in cellular neuroscience, 19, 1642917. https://doi.org/10.3389/fncel.2025.1642917
MLA
Van Zandt, Alison R, et al. "THC reverses SIV-induced senescence in astrocytes: possible compensatory mechanism against HIV associated brain injury?." Frontiers in cellular neuroscience, 2025. https://doi.org/10.3389/fncel.2025.1642917
RethinkTHC
RethinkTHC Research Database. "THC reverses SIV-induced senescence in astrocytes: possible ..." RTHC-07851. Retrieved from https://rethinkthc.com/research/van-2025-thc-reverses-sivinduced-senescence
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.